Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2012, Article ID 151085, 13 pages
http://dx.doi.org/10.1155/2012/151085
Review Article

The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?

1Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow 226014, India
2Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Science, Lucknow 226014, India
3Stomach, Liver and Bowel Clinic, Gleneagles Hospital, Singapore
4Department of Medicine and Therapeutics, Institute of Digestive Disease, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
5Department of Medicine, Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland

Received 15 November 2011; Accepted 7 January 2012

Academic Editor: Takanori Kanai

Copyright © 2012 Uday C. Ghoshal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Ponnusamy, J. N. Choi, J. Kim, S.-Y. Lee, and C. H. Lee, “Microbial community and metabolomic comparison of irritable bowel syndrome faeces,” Journal of Medical Microbiology, vol. 60, no. 6, pp. 817–827, 2011. View at Publisher · View at Google Scholar
  2. E. M. M. Quigley and R. Quera, “Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics,” Gastroenterology, vol. 130, no. 2, supplement 1, pp. S78–S90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Prakash, L. Rodes, M. Coussa-Charley et al., “Gut microbiota: next frontier in understanding human health and development of biotherapeutics,” Biologics, vol. 5, pp. 71–86, 2011. View at Google Scholar
  4. I. Sekirov, S. L. Russell, L. Caetano M Antunes, and B. B. Finlay, “Gut microbiota in health and disease,” Physiological Reviews, vol. 90, no. 3, pp. 859–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Carrara, S. Desideri, M. Azzurro et al., “Small intestine bacterial overgrowth in patients with irritable bowel syndrome,” European Review for Medical and Pharmacological Sciences, vol. 12, no. 3, pp. 197–202, 2008. View at Google Scholar · View at Scopus
  6. E. Malinen, T. Rinttilä, K. Kajander et al., “Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR,” American Journal of Gastroenterology, vol. 100, no. 2, pp. 373–382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Neish, “Microbes in gastrointestinal health and disease,” Gastroenterology, vol. 136, no. 1, pp. 65–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. E. M. Quigley, “Do patients with functional gastrointestinal disorders have an altered gut flora?” Therapeutic Advances in Gastroenterology, vol. 2, no. 4, pp. 23–30, 2009. View at Google Scholar
  9. J. M. Park, M. G. Choi, Y. K. Cho et al., “Functional gastrointestinal disorders diagnosed by Rome III questionnaire in Korea,” Journal of Neurogastroenterology and Motility, vol. 17, no. 3, pp. 279–286, 2011. View at Publisher · View at Google Scholar
  10. M. Teo, S. Chung, L. Chitti et al., “Small bowel bacterial overgrowth is a common cause of chronic diarrhea,” Journal of Gastroenterology and Hepatology, vol. 19, no. 8, pp. 904–909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Posserud, A. Ersryd, and M. Simrén, “Functional findings in irritable bowel syndrome,” World Journal of Gastroenterology, vol. 12, no. 19, pp. 2830–2838, 2006. View at Google Scholar · View at Scopus
  12. H. Park, “The role of small intestinal bacterial overgrowth in the pathophysiology of irritable bowel syndrome,” Journal of Neurogastroenterology and Motility, vol. 16, no. 1, pp. 3–4, 2010. View at Google Scholar
  13. J. Bures, J. Cyrany, D. Kohoutova et al., “Small intestinal bacterial overgrowth syndrome,” World Journal of Gastroenterology, vol. 16, no. 24, pp. 2978–2990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. U. C. Ghoshal, H. Park, and K. A. Gwee, “Bugs and irritable bowel syndrome: the good, the bad and the ugly,” Journal of Gastroenterology and Hepatology, vol. 25, no. 2, pp. 244–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Simrén and P. O. Stotzer, “Use and abuse of hydrogen breath tests,” Gut, vol. 55, no. 3, pp. 297–303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Scanu, T. J. Bull, S. Cannas et al., “Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 3883–3890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Malinen, L. Krogius-Kurikka, A. Lyra et al., “Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome,” World Journal of Gastroenterology, vol. 16, no. 36, pp. 4532–4540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Kassinen, L. Krogius-Kurikka, H. Mäkivuokko et al., “The fecal microbiota of irritable Bowel syndrome patients differs significantly from that of healthy subjects,” Gastroenterology, vol. 133, no. 1, pp. 24–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. I. M. Carroll, Y. H. Chang, J. Park, R. B. Sartor, and Y. Ringel, “Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome,” Gut Pathogens, vol. 2, no. 1, 2010. View at Publisher · View at Google Scholar
  20. A. Lyra, L. Krogius-Kurikka, J. Nikkilä et al., “Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes,” BMC Gastroenterology, vol. 10, p. 110, 2010. View at Publisher · View at Google Scholar
  21. W. G. Thompson, “The road to Rome,” Gastroenterology, vol. 130, no. 5, pp. 1552–1556, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. G. C. Parkes, J. Brostoff, K. Whelan, and J. D. Sanderson, “Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment,” American Journal of Gastroenterology, vol. 103, no. 6, pp. 1557–1567, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. G. K. Makharia, A. K. Verma, R. Amarchand et al., “Prevalence of irritable bowel syndrome: a community based study from northern India,” Journal of Neurogastroenterology and Motility, vol. 17, no. 1, pp. 82–87, 2011. View at Publisher · View at Google Scholar
  24. U. C. Ghoshal, P. Abraham, C. Bhatt et al., “Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force,” Indian Journal of Gastroenterology, vol. 27, no. 1, pp. 22–28, 2008. View at Google Scholar · View at Scopus
  25. K. A. Gwee, C. L. Lu, and U. C. Ghoshal, “Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed,” Journal of Gastroenterology and Hepatology, vol. 24, no. 10, pp. 1601–1607, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Öhman and M. Simrén, “New insights into the pathogenesis and pathophysiology of irritable bowel syndrome,” Digestive and Liver Disease, vol. 39, no. 3, pp. 201–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Karantanos, T. Markoutsaki, M. Gazouli et al., “Current insights in to the pathophysiology of irritable Bowel syndrome,” Gut Pathogens, vol. 2, no. 1, p. 3, 2010. View at Google Scholar
  28. E. K. Brint, J. MacSharry, A. Fanning, F. Shanahan, and E. M.M. Quigley, “Differential expression of toll-like receptors in patients with irritable bowel syndrome,” American Journal of Gastroenterology, vol. 106, no. 2, pp. 329–336, 2011. View at Publisher · View at Google Scholar
  29. D. A. Drossman, “The functional gastrointestinal disorders and the Rome III process,” Gastroenterology, vol. 130, no. 5, pp. 1377–1390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. B. J. Lee and Y. T. Bak, “Irritable bowel syndrome, gut microbiota and probiotics,” Journal of Neurogastroenterology and Motility, vol. 17, no. 3, pp. 252–266, 2011. View at Publisher · View at Google Scholar
  31. J. E. Kellow, F. Azpiroz, M. Delvaux et al., “Applied principles of neurogastroenterology: physiology/motility sensation,” Gastroenterology, vol. 130, no. 5, pp. 1412–1420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Rinttilä, A. Lyra, L. Krogius-Kurikka, and A. Palva, “Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects,” Gut Pathogens, vol. 3, no. 1, 2011. View at Publisher · View at Google Scholar
  33. A. P.M. Kerckhoffs, K. Ben-Amor, M. Samsom et al., “Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome,” Journal of Medical Microbiology, vol. 60, no. 2, pp. 236–245, 2011. View at Publisher · View at Google Scholar
  34. M. Rajilić-Stojanović, E. Biagi, H. G.H.J. Heilig et al., “Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome,” Gastroenterology, vol. 141, no. 5, pp. 1792–1801, 2011. View at Publisher · View at Google Scholar
  35. D. M. Saulnier, K. Riehle, T. -A. Mistretta et al., “Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome,” Gastroenterology, vol. 141, no. 5, pp. 1782–1791, 2011. View at Publisher · View at Google Scholar
  36. A. Salonen, W. M. De Vos, and A. Palva, “Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives,” Microbiology, vol. 156, no. 11, pp. 3205–3215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Le Gall, S. O. Noor, K. Ridgway et al., “Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome,” Journal of Proteome Research, vol. 10, no. 9, pp. 4208–4218, 2011. View at Publisher · View at Google Scholar
  38. S. Vanner, “The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment,” Gut, vol. 57, no. 9, pp. 1315–1321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. A. W. DuPont, “Postinfectious irritable bowel syndrome,” Clinical Infectious Diseases, vol. 46, no. 4, pp. 594–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Jee, W. Morales, K. Low et al., “ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS,” World Journal of Gastroenterology, vol. 16, no. 29, pp. 3680–3686, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. K. Marshall, M. Thabane, A. X. Garg, W. F. Clark, M. Salvadori, and S. M. Collins, “Incidence and epidemiology of irritable Bowel syndrome after a large waterborne outbreak of bacterial dysentery,” Gastroenterology, vol. 131, no. 2, pp. 445–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. D. Parry, R. Stansfield, D. Jelley et al., “Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study,” American Journal of Gastroenterology, vol. 98, no. 9, pp. 1970–1975, 2003. View at Google Scholar · View at Scopus
  43. K. A. Gwee, J. C. Graham, M. W. McKendrick et al., “Psychometric scores and persistence of irritable bowel after infectious diarrhoea,” Lancet, vol. 347, no. 8995, pp. 150–153, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Thabane, D. T. Kottachchi, and J. K. Marshall, “Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 26, no. 4, pp. 535–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. H. A. Halvorson, C. D. Schlett, M. S. Riddle, and M. Al-Haddad, “Postinfectious irritable bowel syndrome—a meta-analysis,” American Journal of Gastroenterology, vol. 101, no. 8, pp. 1894–1942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. H. L. DuPont, G. Galler, F. Garcia-Torres, A. W. DuPont, A. Greisinger, and Z. D. Jiang, “Travel and travelers' diarrhea in patients with irritable bowel syndrome,” American Journal of Tropical Medicine and Hygiene, vol. 82, no. 2, pp. 301–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Thabane and J. K. Marshall, “Post-infectious irritable bowel syndrome,” World Journal of Gastroenterology, vol. 15, no. 29, pp. 3591–3596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. S. K. Sarna, “Lessons learnt from post-infectious IBS,” Frontiers in Physiology, vol. 2, p. 49, 2011. View at Google Scholar
  49. A. Villani, M. Lemire, M. Thabane et al., “Genetic risk factors for post-infectious irritable Bowel syndrome following a waterborne outbreak of gastroenteritis,” Gastroenterology, vol. 138, no. 4, pp. 1502–1513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S. P. Dunlop, J. Hebden, E. Campbell et al., “Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes,” American Journal of Gastroenterology, vol. 101, no. 6, pp. 1288–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Piche, G. Barbara, P. Aubert et al., “Impaired Intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators,” Gut, vol. 58, no. 2, pp. 196–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. K. J. Lee, Y. B. Kim, J. H. Kim, H. C. Kwon, D. K. Kim, and S. W. Cho, “The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors,” Journal of Gastroenterology and Hepatology, vol. 23, no. 11, pp. 1689–1694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. K. A. Gwee, S. M. Collins, N. W. Read et al., “Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome,” Gut, vol. 52, no. 4, pp. 523–526, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. K. J. Lee and J. Tack, “Altered intestinal microbiota in irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 22, no. 5, pp. 493–498, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Chow, S. M. Lee, Y. Shen, A. Khosravi, and S. K. Mazmanian, “Host-bacterial symbiosis in health and disease,” Advances in Immunology, vol. 107, no. C, pp. 243–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. I. Posserud, P. O. Stotzer, E. S. Björnsson, H. Abrahamsson, and M. Simrén, “Small intestinal bacterial overgrowth in patients with irritable bowel syndrome,” Gut, vol. 56, no. 6, pp. 802–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Gasbarrini, E. C. Lauritano, M. Gabrielli et al., “Small intestinal bacterial overgrowth: diagnosis and treatment,” Digestive Diseases, vol. 25, no. 3, pp. 237–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. U. C. Ghoshal, S. Kumar, M. Mehrotra et al., “Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea,” Journal Neurogastroenterology and Motility, vol. 16, no. 1, pp. 40–46, 2010. View at Google Scholar
  59. U. C. Ghoshal, “How to interpret hydrogen breath tests,” Journal of Neurogastroenterology and Motility, vol. 17, no. 3, pp. 312–317, 2011. View at Publisher · View at Google Scholar
  60. S. Chandra, U. Dutta, M. T. Noor et al., “Endoscopic jejunal biopsy culture: a simple and effective method to study jejunal microflora,” Indian Journal of Gastroenterology, pp. 1–5, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Pimentel, E. J. Chow, and H. C. Lin, “Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study,” American Journal of Gastroenterology, vol. 98, no. 2, pp. 412–419, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. U. C. Ghoshal, U. Ghoshal, K. Das, and A. Misra, “Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome, and its relationship with orocecal transit time,” Indian Journal of Gastroenterology, vol. 25, no. 1, pp. 6–10, 2006. View at Google Scholar · View at Scopus
  63. H. K. Berthold, P. Schober, C. Scheurlen et al., “Use of the lactose-[13C]ureide breath test for diagnosis of small bowel bacterial overgrowth: comparison to the glucose hydrogen breath test,” Journal of Gastroenterology, vol. 44, no. 9, pp. 944–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. S. H. Kyoung, W. K. Hyoun, P. I. Jong et al., “Effect of probiotics on symptoms in Korean adults with irritable bowel syndrome,” Gut and Liver, vol. 3, no. 2, pp. 101–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. S. J. Lewis, S. Franco, G. Young, and S. J. D. O'Keefe, “Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole,” Alimentary Pharmacology and Therapeutics, vol. 10, no. 4, pp. 557–561, 1996. View at Google Scholar · View at Scopus
  66. C. Williams and K. E. L. McColl, “Proton pump inhibitors and bacterial overgrowth,” Alimentary Pharmacology and Therapeutics, vol. 23, no. 1, pp. 3–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Fan and J. H. Sellin, “Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea,” Alimentary Pharmacology and Therapeutics, vol. 29, no. 10, pp. 1069–1077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. B. M. R. Spiegel, W. D. Chey, and L. Chang, “Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?” American Journal of Gastroenterology, vol. 103, no. 12, pp. 2972–2976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. E. J. Schiffrin and S. Blum, “Interactions between the microbiota and the intestinal mucosa,” European Journal of Clinical Nutrition, vol. 56, supplement 3, pp. S60–S64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Tanoue, Y. Umesaki, and K. Honda, “Immune responses to gut microbiota-commensals and pathogens,” Gut Microbes, vol. 1, no. 4, pp. 224–233, 2010. View at Google Scholar
  71. S. Vaishnava, C. L. Behrendt, A. S. Ismail, L. Eckmann, and L. V. Hooper, “Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 52, pp. 20858–20863, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. C. L. Ohland and W. K. MacNaughton, “Probiotic bacteria and intestinal epithelial barrier function,” American Journal of Physiology, Gastrointestinal and Liver Physiology, vol. 298, no. 6, pp. G807–G819, 2010. View at Publisher · View at Google Scholar
  73. R. C. Anderson, A. L. Cookson, W. C. McNabb et al., “Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation,” BMC Microbiology, vol. 10, article no. 316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. Z. H. Liu, T. Y. Shen, P. Zhang, Y. L. Ma, M. P. Moyer, and H. L. Qin, “Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460,” World Journal of Gastroenterology, vol. 16, no. 45, pp. 5759–5765, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. Q. Zhou, W. W. Souba, C. M. Croce, and G. N. Verne, “MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome,” Gut, vol. 59, no. 6, pp. 775–784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. H. L. B. M. Klaasen, P. J. Van der Heijden, W. Stok et al., “Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice,” Infection and Immunity, vol. 61, no. 1, pp. 303–306, 1993. View at Google Scholar · View at Scopus
  77. S. K. Mazmanian, J. L. Round, and D. L. Kasper, “A microbial symbiosis factor prevents intestinal inflammatory disease,” Nature, vol. 453, no. 7195, pp. 620–625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Veiga, C. A. Gallini, C. Beal et al., “Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 42, pp. 18132–18137, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. V. Gaboriau-Routhiau, S. Rakotobe, E. Lécuyer et al., “The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses,” Immunity, vol. 31, no. 4, pp. 677–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Liebregts, B. Adam, C. Bredack et al., “Immune activation in patients With irritable Bowel syndrome,” Gastroenterology, vol. 132, no. 3, pp. 913–920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Ohman, S. Isaksson, A. C. Lindmark et al., “T-cell activation in patients with irritable bowel syndrome,” American Journal of Gastroenterology, vol. 104, no. 5, pp. 1205–1212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. V. Z. Rocha and E. J. Folco, “Inflammatory concepts of obesity,” International Journal of Inflammation, vol. 2011, Article ID 529061, 14 pages, 2011. View at Publisher · View at Google Scholar
  83. N. Holmen, S. Isaksson, M. Simren et al., “CD4+CD25+ regulatory T cells in irritable bowel syndrome patients,” Neurogastroenterology & Motility, vol. 19, no. 2, pp. 119–25, 2007. View at Google Scholar
  84. H. C. Lin and K. Al-Khatib, “Immune activation and gut microbes in irritable bowel syndrome,” Gut and Liver, vol. 3, no. 1, pp. 14–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. G. Barbara, “Toll-like receptor expression in irritable bowel syndrome: on the alert for a microbial threat,” American Journal of Gastroenterology, vol. 106, no. 2, pp. 337–339, 2011. View at Publisher · View at Google Scholar
  86. C. O'Mahony, P. Scully, D. O'Mahony et al., “Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation,” PLoS Pathogens, vol. 4, no. 8, Article ID e1000112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. O'Sullivan, Clayton, Breslin et al., “Increased mast cells in the irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 12, no. 5, pp. 449–457, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. B. E. Lacy, K. Weiser, and R. De Lee, “The treatment of irritable bowel syndrome,” Therapeutic Advances in Gastroenterology, vol. 2, no. 4, pp. 221–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. W. D. Chey, M. Maneerattaporn, and R. Saad, “Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome,” Gut and Liver, vol. 5, no. 3, pp. 253–266, 2011. View at Publisher · View at Google Scholar
  90. L. O'Mahony, J. Mccarthy, P. Kelly et al., “Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles,” Gastroenterology, vol. 128, no. 3, pp. 541–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Steer, H. Carpenter, K. Tuohy, and G. R. Gibson, “Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics,” Nutrition Research Reviews, vol. 13, no. 2, pp. 229–254, 2000. View at Google Scholar · View at Scopus
  92. H. J. Kim, M. Camilleri, S. McKinzie et al., “A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 7, pp. 895–904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. H. J. Kim, M. I. Vazquez Roque, M. Camilleri et al., “A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating,” Neurogastroenterology and Motility, vol. 17, no. 5, pp. 687–696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. G. A. Preidis and J. Versalovic, “Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era,” Gastroenterology, vol. 136, no. 6, pp. 2015–2031, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. J. C. Y. Wu, “Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?” Gastroenterology and Hepatology, vol. 6, no. 11, pp. 705–711, 2010. View at Google Scholar · View at Scopus
  96. D. B. A. Silk, A. Davis, J. Vulevic, G. Tzortzis, and G. R. Gibson, “The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 29, no. 5, pp. 508–518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. J. H. Cummings, G. T. Macfarlane, and H. N. Englyst, “Prebiotic digestion and fermentation,” American Journal of Clinical Nutrition, vol. 73, no. 2, supplement, pp. 415S–420S, 2001. View at Google Scholar · View at Scopus
  98. J. Schrezenmeir and M. De Vrese, “Probiotics, prebiotics, and synbiotics - Approaching a definition,” American Journal of Clinical Nutrition, vol. 73, no. 2, pp. 361S–364S, 2001. View at Google Scholar · View at Scopus
  99. S. Gupta, V. Kapoor, and B. Kapoor, “Itopride: a novel prokinetic agent,” Pharmacology, vol. 6, no. 2, pp. 106–108, 2004. View at Google Scholar · View at Scopus
  100. P. Paré, R. Bridges, M. C. Champion et al., “Recommendations on chronic constipation (including constipation associated with irrtable bowel syndrome) treatment,” Canadian Journal of Gastroenterology, vol. 21, supplement B, pp. 3B–22B, 2007. View at Google Scholar
  101. D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger, and A. L. Blum, “Meta-analysis: the treatment of irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 20, no. 11-12, pp. 1253–1269, 2004. View at Publisher · View at Google Scholar
  102. C. L. Frissora and B. D. Cash, “The role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 11, pp. 1271–1281, 2007. View at Publisher · View at Google Scholar
  103. K. Tillisch and L. Chang, “Diagnosis and treatment of irritable bowel syndrome: state of the art,” Current Gastroenterology Reports, vol. 7, no. 4, pp. 249–256, 2005. View at Google Scholar · View at Scopus
  104. H. C. Lin, “Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome,” Journal of the American Medical Association, vol. 292, no. 7, pp. 852–858, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Pimentel, A. Lembo, W. D. Chey et al., “Rifaximin therapy for patients with irritable bowel syndrome without constipation,” New England Journal of Medicine, vol. 364, no. 1, pp. 22–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. J. Maukonen, R. Satokari, J. Mättö, H. Söderlund, T. Mattila-Sandholm, and M. Saarela, “Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria,” Journal of Medical Microbiology, vol. 55, no. 5, pp. 625–633, 2006. View at Publisher · View at Google Scholar
  107. A. P. M. Kerckhoffs, M. Samsom, M. E. van der Rest et al., “Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients,” World Journal of Gastroenterology, vol. 15, no. 23, pp. 2887–2892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. B. M. Sobieszczańska, J. Osek, D. Waśko-Czopnik, E. Dworniczek, and K. Jermakow, “Association of enteroaggregative Escherichia coli with irritable bowel syndrome,” Clinical Microbiology and Infection, vol. 13, no. 4, pp. 404–407, 2007. View at Publisher · View at Google Scholar
  109. A. Lyra, T. Rinttilä, J. Nikkilä et al., “Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification,” World Journal of Gastroenterology, vol. 15, no. 47, pp. 5936–5945, 2009. View at Publisher · View at Google Scholar
  110. L. Krogius-Kurikka, A. Lyra, E. Malinen et al., “Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers,” BMC Gastroenterology, vol. 9, article no. 95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. J. M. Si, Y. C. Yu, Y. J. Fan, and S. J. Chen, “Intestinal microecology and quality of life in irritable bowel syndrome patients,” World Journal of Gastroenterology, vol. 10, no. 12, pp. 1802–1805, 2004. View at Google Scholar · View at Scopus
  112. C. Codling, L. O'Mahony, F. Shanahan, E. M. M. Quigley, and J. R. Marchesi, “A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome,” Digestive Diseases and Sciences, vol. 55, no. 2, pp. 392–397, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Tana, Y. Umesaki, A. Imaoka, T. Handa, M. Kanazawa, and S. Fukudo, “Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 22, no. 5, pp. 512–e115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. S.C. Ng, E. Lam, T. Y. Lam et al., “Pyrosequencing alalysis reveals high level phylogenetic alterations in mucosal—associated intestinal microbiota of patients with irritable bowel syndrome,” Gut, vol. 60, 2011. View at Google Scholar
  115. J. S. Park, J. H. Yu, H. C. Lim et al., “Usefulness of lactulose breath test for the prediction of small intestinal bacterial overgrowth in irritable bowel syndrome,” The Korean Journal of Gastroenterology, vol. 56, no. 4, pp. 242–248, 2010. View at Google Scholar
  116. E. Scarpellini, V. Giorgio, M. Gabrielli et al., “Prevalence of small intestinal bacterial overgrowth in children with irritable Bowel syndrome: a case-control study,” Journal of Pediatrics, vol. 155, no. 3, pp. 416–420, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. N. S. Mann and M. Limoges-Gonzales, “The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome,” Hepato-Gastroenterology, vol. 56, no. 91-92, pp. 718–721, 2009. View at Google Scholar · View at Scopus
  118. G. Nucera, M. Gabrielli, A. Lupascu et al., “Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 11, pp. 1391–1395, 2005. View at Publisher · View at Google Scholar
  119. S. Sachdeva, A. K. Rawat, R. S. Reddy, and A. S. Puri, “Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors,” Journal of Gastroenterology and Hepatology, vol. 26, supplement 3, pp. 135–138, 2011. View at Publisher · View at Google Scholar
  120. S. C. Reddymasu, S. Sostarich, and R. W. McCallum, “Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?” BMC Gastroenterology, vol. 10, article no. 23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. A. C. Ford, B. M.R. Spiegel, N. J. Talley, and P. Moayyedi, “Small intestinal bacterial overgrowth in irritable Bowel syndrome: systematic review and meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 12, pp. 1279–1286, 2009. View at Publisher · View at Google Scholar
  122. A. Parodi, P. Dulbecco, E. Savarino et al., “Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution,” Journal of Clinical Gastroenterology, vol. 43, no. 10, pp. 962–966, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. S. V. Rana, S. K. Sinha, A. Sikander, D. K. Bhasin, and K. Singh, “Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case control study,” Tropical Gastroenterology, vol. 29, no. 1, pp. 23–25, 2008. View at Google Scholar · View at Scopus
  124. M. Majewski and R. W. McCallum, “Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial,” Advances in medical sciences, vol. 52, pp. 139–142, 2007. View at Google Scholar · View at Scopus
  125. L. Cuoco and M. Salvagnini, “Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin,” Minerva Gastroenterologica e Dietologica, vol. 52, no. 1, pp. 89–95, 2006. View at Google Scholar
  126. A. Lupascu, M. Gabrielli, E. C. Lauritano et al., “Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 22, no. 11-12, pp. 1157–1160, 2005. View at Publisher · View at Google Scholar
  127. M. Grover, M. Kanazawa, O. S. Palsson et al., “Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress,” Neurogastroenterology and Motility, vol. 20, no. 9, pp. 998–1008, 2008. View at Publisher · View at Google Scholar · View at Scopus